NCT02371707View on ClinicalTrials.gov

Bioequivalence Study of Idalopirdine Tablets 60 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

Idalopirdine 60 mg formulation A (test)

Tablet for oral use, single dose

DRUG

Idalopirdine 60 mg formulation B (reference)

Tablet for oral use, single dose

Trial Locations (1)

Unknown

Covance, Leeds

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02371707 - Bioequivalence Study of Idalopirdine Tablets 60 mg | Biotech Hunter | Biotech Hunter